Results 61 to 70 of about 4,196 (141)

A Systematic Review of Ocular Complications Following Different Types of Covid‐19 Vaccines

open access: yesJournal of Immunology Research, Volume 2025, Issue 1, 2025.
Introduction More than 6 million deaths from the novel coronavirus, the Coronavirus disease 2019 (COVID‐19) infection, have prompted the development of several prophylactic vaccines of COVID‐19. This systematic review summarizes the ocular complications of various COVID‐19 vaccinations, diseases diagnosed, treatment, and risk factors.
Bahareh Ebrahimi   +4 more
wiley   +1 more source

Blood transcriptome profiling reveals distinct gene networks induced by mRNA vaccination against COVID‐19

open access: yesEuropean Journal of Immunology, Volume 54, Issue 11, November 2024.
Using an unsupervised weighted gene correlation analysis on blood transcriptomes pre‐ and post‐COVID‐19 mRNA vaccination, we identify distinct gene networks that are up‐ and downregulated in response to vaccination. A particular interferon‐associated network significantly correlated with induced antibody levels and was further characterized, for ...
Lennart Riemann   +11 more
wiley   +1 more source

Strong and early immune responses against SARS-CoV-2 in mice and rhesus macaques after BNT162b3 vaccination

open access: yesnpj Vaccines
We preclinically characterize BNT162b3, a nucleoside-modified mRNA-based coronavirus disease 2019 (COVID-19) vaccine encoding a trimerized, cell surface-tethered severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike receptor-binding domain ...
Annette B. Vogel   +19 more
doaj   +1 more source

Emerg Infect Dis

open access: yes
Reducing severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) transmission is a worldwide challenge; widespread vaccination could be one strategy for control.

core   +3 more sources

Information about the Pfizer-BioNTech COVID-19 Vaccine

open access: yes
Updated July 14, 2022Recommended for People 6 Months and OlderPrimary Series:\u2022 5 Years and Older: 2 doses of Pfizer-BioNTech in the primary series, given 3\u20138 weeks apart.

core   +3 more sources

Factors to get sick from COVID-19.

open access: yes, 2023
ObjectivesThe objective of this study is to estimate the effectiveness of COVID-19 vaccines in people treated within the social security system whose vaccination status was reported to the epidemiological surveillance system.Study designCase-control ...
Concepción Grajales Muñiz (16748112)   +9 more
core   +1 more source

Comorbility in cases and controls of COVID-19.

open access: yes, 2023
ObjectivesThe objective of this study is to estimate the effectiveness of COVID-19 vaccines in people treated within the social security system whose vaccination status was reported to the epidemiological surveillance system.Study designCase-control ...
Concepción Grajales Muñiz (16748112)   +9 more
core   +1 more source

Pfizer-BioNTech COVID-19 vaccine : standing orders for administering vaccine : 12 years of age and older (purple cap)

open access: yes
To reduce morbidity and mortality from coronavirus disease 2019 (COVID-19) by vaccinating persons who meet the criteria established by the Centers for Disease Control and Prevention\u2019s Advisory Committee on Immunization Practices (ACIP).CS321570 ...

core   +3 more sources

Morbidity and Mortality Weekly Report (MMWR)

open access: yes
Cardiac Complications, particularly myocarditis and pericarditis, have been associated with SARS-CoV-2 (the Virus that causes COVID-19) infection (1-3) and mRNA COVID-19 vaccination (2-5).

core   +2 more sources

Home - About - Disclaimer - Privacy